This accredited OncoBlast activity “Optimizing Immuno-Oncology: Innovations in Immune Checkpoint Inhibitor Delivery” is designed to engage learners through interactive, case-based challenges focused on evolving strategies for administering immune checkpoint inhibitors (ICIs). Covering both intravenous (IV) and subcutaneous (SC) delivery methods across multiple tumor types, this activity equips oncology care providers with practical tools to evaluate delivery options, manage adverse events, and integrate SC ICI approaches into real-world practice.

Course Accreditations

Course Summary

Target Audience

Medical Oncologists
Fellows
Advanced Practice Providers
Pharmacists
Nurses

Learning Objectives

Upon successful completion of this educational activity, participants will be able to:

Compare the benefits and limitations of IV vs. SC ICI delivery across tumor types.
Summarize evidence on efficacy, safety, and pharmacokinetics of SC ICIs.
Implement approaches to monitor and manage SC ICI-related adverse events.